X-ray fluoroscopy
Taipei, 100, Taiwan
NCT Number: NCT00173836
Significant evidence has shown that radiation therapy for patients with nasopharyngeal cancer (NPC) can cause swallowing abnormality. Based on our prior cross-sectional study for 184 NPC patients from 1995 to 1999, the findings of videofluoroscopic swallowing study (VFSS) revealed continuous deterioration of swallowing function of these patients even many years after radiation. We conducted a prospective study to evaluate the longitudinal change of swallowing function based on VFSS before, one month, one year and two years after completing radiation therapy. The amount of saliva was measured at the same time of VFSS study to test the relationship of decreased amount of saliva and swallowing function. Comparison of serial VFSS studies in NPC patients (n=84) and normal volunteers (n=38) were obtained. We assume that this study may reveal a complete understanding of changing swallowing patterns in the course of radiation therapy of patients with NPC. From this study, NPC patients can understand their own swallowing function. Therefore, the information may enable for earlier intervention of swallowing training or correction to avoid morbidity of radiation therapy in this patient group.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Taipei, 100, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Nasopharyngeal cancer patients > 20 yrs.
Exclusion criteria
pregnant women
National Taiwan University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04528394
Carcinoma, Head and Neck Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03240835
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT03848286
Carcinoma, Disease Attributes
Beijing, Beijing Municipality, China
View Trial DetailsNCT02633202
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial Details